STSA - SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RXDX STSA CHRA

NEW YORK, NY / ACCESSWIRE / April 21, 2023 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:

Prometheus Biosciences, Inc. (NASDAQ:RXDX)'s sale to Merck for $200.00 per share in cash. If you are a Prometheus shareholder, click here to learn more about your rights and options.

Satsuma Pharmaceuticals, Inc. (NASDAQ:STSA)'s sale to Shin Nippon Biomedical Laboratories, Ltd. for $0.91 in cash per share at the closing of the transaction plus one non-tradeable contingent value right of up to $5.77 per share.If you are a Satsuma shareholder, click here to learn more about your rights and options.

Charah Solutions, Inc. (OTC:CHRA)'s sale to SER Capital Partners for $6.00 per share.If you are a Charah shareholder, click here to learn more about your rights and options.

Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders.

Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email sadeh@halpersadeh.com or zhalper@halpersadeh.com.

Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

Halper Sadeh LLP
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
sadeh@halpersadeh.com
zhalper@halpersadeh.com
https://www.halpersadeh.com

SOURCE: Halper Sadeh LLP